sup 18^F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumou...
sup 18^F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type
About this item
Full title
Author / Creator
Publisher
Heidelberg: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Heidelberg: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
6-Fluoro-(^sup 18^F)-L-3,4-dihydroxyphenylalanine (FDOPA) is an amino acid analogue for positron emission tomography (PET) imaging which has been registered since 2006 in several European Union (EU) countries and by several pharmaceutical firms. Neuroendocrine tumour (NET) imaging is part of its registered indications. NET functional imaging is a v...
Alternative Titles
Full title
sup 18^F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1348292564
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1348292564
Other Identifiers
ISSN
1619-7070
E-ISSN
1619-7089
DOI
10.1007/s00259-013-2342-x
